CHR Metz-Thionville
Metz, 57085, France
NCT Number: NCT03405051
Hypokalemia is very common in heart failure patients. Deleterious effects have been report on the cardiovascular system. Most of the clinical data concerning this ionic trouble are based on post-hoc study and some findings seemed disjointed.
Looking for future studies?
Notify MeAll sexes
Observational
Metz, 57085, France
This study tried to describe hypokalemia impact during hospital stay in hospitalized patients with heart failure and particularly on mortality and re-hospitalization.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Month 3
The number of death for any reason and re-hospitalization for congestive heart failure
Time frame: Month 3
Percentage of death for any reason
Time frame: Month 3
Percentage of re-hospitalization for congestive heart failure
Time frame: Month 3
Days spent at the hospital
Time frame: Month 3
Percentage of incidence during the stay of hypokalemia
Time frame: Month 3
Percentage of initial prevalence during the stay of hypokalemia
Centre Hospitalier Régional Metz-Thionville
Other
Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit: Morbidity-mortality Impact
Acronym: HYPIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01431326
Adenoviridae Infections, Adenovirus
Anchorage, Alaska, United States
View Trial DetailsNCT05184998
Cardiovascular Diseases, Heart Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03446651
Cardiovascular Diseases, Heart Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT05806606
Behavior, Cardiovascular Diseases
Hong Kong
View Trial Details